Image for CLL International Prognostic Index (CLL-IPI)

CLL International Prognostic Index (CLL-IPI)

The CLL International Prognostic Index (CLL-IPI) is a tool used by doctors to assess the outlook or prognosis for patients with chronic lymphocytic leukemia (CLL). It considers key factors such as patient age, disease stage, genetic changes in the cancer cells, and the presence of certain health issues. By evaluating these criteria, the CLL-IPI helps categorize patients into different risk groups. This information guides treatment decisions and helps predict how well a patient might respond to therapy and how long they may live with the disease.

Additional Insights

  • Image for CLL International Prognostic Index (CLL-IPI)

    The CLL International Prognostic Index (CLL-IPI) is a tool used to predict how a person with chronic lymphocytic leukemia (CLL) might respond to treatment and their overall outlook. It takes into account several factors, including age, stage of the disease, and certain lab results. By scoring these factors, healthcare providers can classify patients into different risk groups, helping to guide treatment decisions and manage care effectively. Essentially, it helps doctors understand the likely course of the disease for individual patients.